Correction
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Oncol. Oct 15, 2022; 14(10): 2085-2087
Published online Oct 15, 2022. doi: 10.4251/wjgo.v14.i10.2085
Correction to “Genome-wide CRISPR-Cas9 screening identifies that hypoxia-inducible factor-1a-induced CBX8 transcription promotes pancreatic cancer progression via IRS1/AKT axis”
Bu-Wei Teng, Kun-Dong Zhang, Yu-Han Yang, Zeng-Ya Guo, Wei-Wei Chen, Zheng-Jun Qiu
Bu-Wei Teng, Department of General Surgery, Shanghai General Hospital of Nanjing Medical University, Shanghai 200080, China
Bu-Wei Teng, Department of General Surgery, Lianyungang Clinical College of Nanjing Medical University/The First People’s Hospital of Lianyungang, Lianyungang 222061, Jiangsu Province, China
Kun-Dong Zhang, Yu-Han Yang, Zeng-Ya Guo, Wei-Wei Chen, Zheng-Jun Qiu, Department of General Surgery, Shanghai General Hospital, Shanghai 200080, China
Author contributions: Teng BW found and corrected the misused figure; Zhang KD, Yang YH, Guo ZY, Chen WW, and Qiu ZJ checked the correction.
Conflict-of-interest statement: There are no conflicts of interest to report.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Zheng-Jun Qiu, MD, Chief Doctor, Director, Surgeon, Department of General Surgery, Shanghai General Hospital, No. 100 Haining Road, Shanghai 200080, China. zhengjun.qiu@shgh.cn
Received: April 6, 2022
Peer-review started: April 6, 2022
First decision: June 12, 2022
Revised: June 15, 2022
Accepted: September 13, 2022
Article in press: September 13, 2022
Published online: October 15, 2022
Processing time: 190 Days and 4.5 Hours
Abstract

Correction to “Genome-wide CRISPR-Cas9 screening identifies that hypoxia-inducible factor-1a-induced CBX8 transcription promotes pancreatic cancer progression via IRS1/AKT axis” (PMID: 34853645 PMCID: PMC8603463 DOI: 10.4251/wjgo.v13.i11.1709). In this article, the picture of Figure 6C was misused due to our carelessness while typesetting. We corrected this mistake, and replaced the incorrect image with the correct one.

Keywords: Correction; Error; Figure; CRISPR-Cas9

Core Tip: Correction to “Genome-wide CRISPR-Cas9 screening identifies that hypoxia-inducible factor-1a-induced CBX8 transcription promotes pancreatic cancer progression via IRS1/AKT axis.”